Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGX-4010 in HIV-AN or PHN
NCT00233155Phase 2Completed
- Sponsor
- NeurogesX
- Start
- Aug 2005
- Modality
- Transdermal Patches, Small Molecules
01
Overview
A Phase 2 trial of capsaicin 8% patch in HIV-associated neuropathy, postherpetic neuralgia (PHN), sponsored by NeurogesX. Started Aug 2005; status: completed.
02
Drugs
capsaicin 8% patch
03
Conditions
HIV-associated neuropathypostherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00233155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00233155.